Study Design. Subgroup analysis of prospective, randomized database from the spine patient outcomes research trial (SPORT) Objective. The hypothesis of this study was that patients who received ESI during initial treatment as part of SPORT (The Spine Patient Outcomes Research Trial) would have improved clinical outcome and a lower rate of crossover to surgery than patients who did not receive ESI. Summary of Background Data. The use of epidural steroid injection (ESI) in patients with lumbar spinal stenosis is common, although there is little evidence in the literature to demonstrate its long-term benefi t in the treatment of lumbar stenosis. Methods. Patients with lumbar spinal stenosis who received ESI within the fi rst 3 months of enrollment in SPORT (ESI) were compared with patients who did not receive epidural injections during the fi rst 3 months of the study (no-ESI).
L umbar spinal stenosis (LSS) is a common condition in the adult population. Most patients with LSS remain asymptomatic and require no further treatment. For individuals who develop symptoms, nonoperative treatment is usually successful. Nonoperative treatment of LSS can include the use of analgesic medications, exercise, physical therapy, and/or epidural injections. Epidural steroid injections (ESIs) are often employed in the nonsurgical treatment of LSS and can be delivered either via an interlaminar or transforaminal route. A survey of spinal surgeons indicates that the majority (69%) consider ESI to represent the fi rst-line invasive treatment of LSS after a course of conservative management has failed to provide signifi cant relief. 1 This high rate of ESI use continues P < 0.001). There was an average 26-minute increase in operative time and an increased length of stay by 0.9 days among the ESI patients who ultimately underwent surgical treatment. Averaged over 4 years, there was signifi cantly less improvement in 36-Item Short Form Health Survey (SF-36) Physical Function among surgically treated ESI patients (ESI 14.8 vs . no-ESI 22.5, P = 0.025). In addition, there was signifi cantly less improvement among the nonsurgically treated patients in SF-36 Body Pain (ESI 7.3 vs . no-ESI 16.7, P = 0.007) and SF-36 Physical Function (ESI 5.5 vs . no-ESI 15.2, P = 0.009). Of the patients assigned to the surgical treatment group, there was a signifi cantly increased crossover to nonsurgical treatment among patients who received an ESI (ESI 33% vs . no-ESI
MATERIALS AND METHODS

Study Design
SPORT was conducted at 13 multidisciplinary spine practices in 11 states. The institutional review boards at each center approved the standardized protocol. SPORT included a randomized cohort and a concurrent observational cohort. In this subgroup analysis, the patients from the randomized and observational cohorts were combined into a single study. The methods used to study the lumbar stenosis cohort of SPORT have been detailed in previous reports. 6 , 7 The plausibility of the observed subgroup analyses effects was reviewed using a set of established guidelines for the interpretation of subgroup analyses of prospective, randomized studies. The results of this checklist are reported in Appendix 1 (Supplemental Digital Content 1, available at http://links.lww.com/BRS/A722 ). 8 
Patient Population
Inclusion criteria in the SPORT spinal stenosis cohort were neurogenic claudication or radicular leg pain with associated neurological signs, spinal stenosis as seen on cross-sectional imaging, symptoms that had persisted for at least 12 weeks, and physician confi rmation that enrolled patients were surgical candidates should they be randomized to the surgical wing. Exclusion criteria were spondylolysis and/or spondylolisthesis. Enrollment began in March 2000 and ended in February 2005. Patients were offered the choice of enrollment into the prospective randomized arm or into the observational arm. For this study, the randomized and observational cohorts were combined for the purpose of analyzing a single cohort with an "as-treated" methodology in large part due to extensive crossover in the randomized cohort.
Study Interventions
The protocol surgery consisted of standard posterior laminectomy with or without bilateral partial facetectomy and foraminotomy per the preferences of the treating surgeon. The nonoperative protocol was "usual recommended care," including ESI, active physical therapy, education and counseling with instructions regarding home exercise, and nonsteroidal anti-infl ammatory drugs if tolerated by the patient.
Study Measures
Primary outcome measures were the 36-Item Short Form Health Survey (SF-36), 9 , 10 Bodily Pain (BP) and Physical Function (PF) subscale scores, and the AAOS MODEMS version of the Oswestry Disability Index (ODI) 11 measured at 6 weeks, 3 months, 6 months, and yearly up to 4 years after enrollment. Secondary outcomes included the Stenosis Bothersomeness Index, the Low Back Pain Bothersomeness Scale, and the Leg Pain Bothersomeness Scale, which were recorded at the same time points. There was a trend toward less improvement in ODI during the 4-year study period among both surgically (ESI − 16.6 vs. no-ESI − 20.3, P = 0.15) and nonsurgically (ESI − 5.3 vs. no-ESI − 10.2, P = 0.075) treated patients. There were no signifi cant differences in treatment effect of surgery between the 2 groups during the study period in any outcome measure.
The adjusted change in primary and secondary outcome measures at each time point is displayed in Table 4 and Figure 2 . The longest follow-up available was 4 years. In the surgically treated ESI patients, there was signifi cantly less improvement at 4 years in SF-36 BP (ESI 18.4 vs . no-ESI 28.4, P = 0.042) and ODI (ESI − 11.7 vs . no-ESI − 19.7, P = 0.033) and a trend in SF-36 PCS (ESI 4.5 vs . no-ESI 8.6, P = 0.051). Furthermore, there was signifi cantly less improvement at 4 years in surgically treated ESI patients in secondary outcome measures such as Sciatica Bothersomeness Index (ESI − 5.8 vs . no-ESI − 8.8, P = 0.032) and patient satisfaction (ESI 41.9 vs . no-ESI 70.9, P = 0.019). In the nonsurgically treated ESI patients, there was signifi cantly less improvement at 4 years in SF-36 BP (ESI 3.7 vs . no-ESI 16.6, P = 0.023), SF-36 PF (ESI 0.9 vs . no-ESI 15.2, P = 0.011), and SF-36 PCS (ESI − 0.2 vs . no-ESI 6.5, P = 0.004). There was a trend toward less improvement in the nonsurgically treated patients in ODI the SPORT study were categorized as the "no-ESI" group. To assess the effect of ESI fairly, we excluded the patients who received prior to enrollment in SPORT because these patients may have failed to respond to ESI initially. We also deliberately excluded those who received ESI "later" in treatment (Ͼ3 mo after enrollment) because these might have been performed as a "salvage intervention" among patients destined to have a poorer outcome.
The primary analyses compared baseline demographic and clinical factors, operative details, and change in the clinical outcome measures within each treatment arm ( i.e. , surgery or nonoperative) between the ESI and no-ESI groups. The treatment effect of surgery was the differential improvement in the outcome of surgically decompressed patients and nonsurgically treated patients. Treatment effect of surgery was compared between ESI and non-ESI patients.
Statistical modeling was performed with the SAS software (version 9.1; SAS Institute, Cary, NC), with the procedures PROC MIXED, and the S-PLUS software (version 6.2; Insightful, Seattle, WA) was used for all other calculations. Signifi cance was defi ned as P < 0.05 on the basis of 2-sided hypothesis testing.
RESULTS
The study included 69 patients who received ESI ("ESI") within the fi rst 3 months of enrollment and 207 patients who did not receive any ESI ("no-ESI") ( Figure 1 ). Overall, 77% (154) of the patients who received ESI during the SPORT study period (n = 200) had them within the fi rst 3 months of enrollment. There were no signifi cant baseline demographic differences between groups in age, sex, ethnicity, race, education, income, marital status, work status, compensation, mean body mass index, smoking status, or comorbidities. Baseline characteristics and demographics of the ESI cohort are shown in Table 1 .
There were no statistically signifi cant differences between groups in baseline primary outcome measures (SF-36 BP, SF-36 PF, SF-36 Physical Component Summary [PCS], SF-36 Mental Component Summary [MCS], ODI), Stenosis Bothersomeness Index, Low Back Pain Bothersomeness Scale, Leg Pain Bothersomeness Scale, satisfaction with symptoms, or patient self-assessed health trend. There was a trend toward worse baseline Stenosis Frequency Index (ESI 15 vs . no-ESI 13.5, P = 0.051) in the ESI patients. There was a signifi cant difference in treatment preference at baseline between groups, with the ESI patients having a signifi cantly increased preference for nonsurgical treatment (ESI 62% vs . no-ESI 33%, P < 0.001) ( Table 1 ). There were no signifi cant baseline differences between groups in clinical presentation or symptom severity (pseudoclaudication, positive straight leg raise, pain radiation, neurological defi cit, refl exes, sensory defi cit, motor weakness, stenosis levels, stenotic levels, stenosis locations, stenosis severity) or the percentage of patients who received surgery ( Table 1 ) .
Operative treatments, complications, and events are compared between the ESI and no-ESI groups in Table 2 . There were no statistically signifi cant differences in procedure details at 4 years (ESI − 5.7 vs. no-ESI − 11.7, P = 0.17). There were no signifi cant differences in secondary outcome measures between the ESI and no-ESI groups treated nonsurgically at 1-, 2-, 3-, or 4-year time points. There were no signifi cant differences in treatment effect of surgery at 4 years. Crossover from assigned or chosen treatment at enrollment to fi nal treatment is displayed in Table 5 . Of the patients assigned to the surgical treatment group, there was a significantly increased crossover to nonsurgical treatment among patients who received an ESI (ESI 33% vs . no-ESI 11%, P = 0.012). Of the patients assigned to the nonoperative treatment group, there was a signifi cantly increased crossover to surgical treatment in the ESI patients (ESI 58% vs . no-ESI 32%, P = 0.003).
The results of the entire ESI (n = 452) versus no-ESI (n = 182) cohorts, including patients who received preenrollment ESI and those who received ESI more than 3 months after enrollment in SPORT, are reported in Table 6 (Supplemental Digital Content 2, available at http://links. lww.com/BRS/A723 ). At baseline, there was signifi cantly lower incidence of patient satisfaction in the ESI cohort (ESI 71% vs. no-ESI 62%, P = 0.026). There was an increased incidence of pain radiation in the ESI cohort (ESI 82% vs. no-ESI 71%, P = 0.006), any neurological defi cit (ESI 58% vs . no-ESI 47%, P = 0.016). There were higher percentages of patients with asymmetric motor (ESI 31% vs . no-ESI 20%, P = 0.005) and refl ex (ESI 29% vs . no-ESI 19%, P = 0.011) abnormalities in the total ESI population at baseline. This difference in motor weakness and refl ex abnormalities was not refl ected in PF score differences between the ESI and no-ESI groups (SF-36 PF domain or ODI). Operative details for the entire ESI cohort are reported in Table 7 (Supplemental Digital Content 2, available at http://links. lww.com/BRS/A723 ). In the ESI patients, there was an increased operative time (ESI 135 min vs . no-ESI 115 min, P = 0.006) and increased length of stay (ESI 3.4 d vs . no-ESI 2.7 d, P = 0.003). Average change in outcome for all the ESI and no-ESI patients is reported in 
DISCUSSION
These results demonstrate signifi cantly less improvement in the ESI patients whether treated surgically or nonsurgically during the 4-year study period. There was also increased operative time and increased length of hospital stay in the ESI patients. Despite the common treatment practice of incorporating 1 or more ESIs in the initial nonoperative management of patients with spinal stenosis, these results suggest that ESI are associated with worse outcome in the treatment of spinal stenosis.
These results are in contrast to the previous ESI literature. Several previous studies have demonstrated improved outcome after ESI, although many ESI studies in the historical literature are uncontrolled studies from which it is diffi cult to separate the waxing/waning natural history of spinal stenosis and any potential treatment effect. For instance, recently, Briggs et al 13 in a prospective observational study demonstrated a declining benefi t to ESI in patients with lumbar stenosis at 1 and 3 months and showed greater effi cacy in patients with better emotional health and those who were obese, but the study was limited by the lack of any control group. In a retrospective study with telephone follow-up of 3 years, Lee et al 14 demonstrated that whereas 70% of patients had recurrent symptoms and only 49% would undergo the procedure again. Additionally, nearly 40% reported lasting relief at fi nal follow-up, although no outcome predictors of success could be identifi ed. This study also did not include a control group.
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the patients with disc herniation or spinal stenosis or only among the aggregate group. A recent update from the same investigators 16 with a minimum follow-up of 5 years found that 17 of 21 patients continued to avoid surgery, although the difference in surgical avoidance between patients treated with ESI and those treated with a local anesthetic only was no longer statistically signifi cant. Cuckler et al 17 found no lasting benefi t to ESI in a prospective randomized trial at an average follow-up of 20 months, classifying more than two-thirds of patients with lumbar stenosis who received ESI as treatment failures and demonstrating no benefi t to receiving a second injection in cases where the fi rst was ineffective in alleviating A prospective, randomized, controlled study performed by Koc et al 15 demonstrated improved functional outcomes at 6 months in patients treated with ESI versus a control group of patients treated with nonsteroidal anti-infl ammatory drugs and home exercise. Riew et al 2 performed a prospective, randomized, controlled study of ESI versus injection with local anesthetic alone. The authors demonstrated greater surgical avoidance in the group treated with ESI at a fi nal follow-up that averaged 23 months. The study cohort, however, comprised patients with either spinal stenosis or lumbar disc herniation, and the data are not suffi ciently specifi c to diagnosis to ascertain whether surgical avoidance was found only among dissipated. ESIs have also been hypothesized to exacerbate epidural lipomatosis. 22 , 23 Another possible explanation is that the ESI may temporarily mask protective painful stimuli and otherwise relieve patients who would be limited by pain. Thus, ESIs may temporarily diminish pain but may actually potentiate damage to the nerve roots in the long term, which ultimately diminishes clinical outcomes even after a successful decompression operation. Other possible explanations for poor results after ESI include the possibility of a nerve injury or scarring from toxicity of the lidocaine, corticosteroid, or a carrier agent. Local anesthetics and preservatives in corticosteroids have been demonstrated to be toxic after intra-articular injections 24 , 25 and more recently in culture with intervertebral disc cells. 26 It is possible that subtle toxicity of the steroids 27 -29 or local anesthetics directly injure neuronal 30 -32 or glial elements. 33 We think that these results call for further detailed study of the biological effects of ESI.
These results provide confl icting data on surgical avoidance after ESI. Of the patients who were assigned or who chose surgery, there were increased percentages of patients who crossed over to nonsurgical treatment (ESI 33% vs . non-ESI 11%, P = 0.012). However, of the patients who were designated to undergo nonsurgical treatment, there were increased percentages of patients who elected to undergo surgical intervention (ESI 58% vs . no-ESI 32%, P = 0.003). Therefore, ESIs were associated with increased crossover both to and from surgical intervention. Because there was less improvement in the nonsurgically treated patients than in the surgically treated patients at all time points, some of the patients who crossed over to nonsurgical treatment may have ultimately achieved less improvement in outcome than they would have otherwise achieved. Our results suggest that patients who received ESI had less improvement after surgery and that surgical ESI patients had longer operative times and longer postoperative lengths of stay than patients who underwent surgery without preoperative ESI. There were no statistically signifi cant differences at baseline between the surgically treated ESI and no-ESI groups in the type of surgery, severity of stenosis, number of levels decompressed, and postoperative complications to explain this difference otherwise. One explanation for the inferior results and increased surgical duration is that ESI may result in increased adhesions or scarring, increasing the complexity of surgical decompression. However, the fi ndings of increased operative time and blood loss were unexpected and therefore may be coincidental and unrelated to ESI. There were trends to suggest an increased incidence of multilevel and instrumented fusions in the ESI patients that we acknowledge may confound the analysis of operative time, particularly in the absence of a fi nding such as increased dural tear rate that may be more directly related to the ESI. The secondary analysis to exclude patients who underwent fusion did not display a statistically signifi cant difference in operative time between groups.
There are several limitations to this study including the fact that this was a retrospective subgroup analysis that was not specifi ed a priori. The technique of administration of epidural injections was heterogeneous, although a recent study symptoms. Fukusaki et al 18 found no difference in walking distance between patients treated with local anesthetic injection and ESI in a prospective, randomized, controlled trial with a follow-up of 3 months. At the fi nal follow-up, both the local anesthetic and ESI groups had good or excellent results in only approximately 5% of enrolled patients. In a large retrospective study, Friedly et al 19 similarly demonstrated increased rates of surgical intervention and opioid use after ESI after follow-up of 6 months in more than 10,000 patients with spinal stenosis.
In contrast to some of the previous studies, we studied a prospectively collected, large population with a single anatomical and clinical diagnosis and well-defi ned inclusion and exclusion criteria. Previous studies often mix patients with spinal stenosis with patients with degenerative spondylolisthesis, whereas this study excluded patients with spondylolisthesis or instability. 20 , 21 We included only those patients who did not receive ESI prior to enrollment in SPORT to avoid a potential confounder from a treatment failure of an early epidural injection prior to enrollment in the study or from a later ESI given as a salvage procedure after failing other nonoperative treatments. The outcome effect was observed in several different general and disease-specifi c outcome measures including SF-36 and Bothersomeness Index. However, this effect was not observed in ODI, a lumbar spine-specifi c outcome measure. Furthermore, this study compares injection versus noninjection as a methodology in contrast to most studies that evaluate the effect of injection versus placebo injection. Several previous studies have relied on administrative databases using Current Procedural Terminology and International Classifi cation of Diseases coding, although these may not be as precise for the identifi cation of symptomatic spinal stenosis and exclusion of patients with spondylolisthesis. This study also includes patients treated surgically and nonsurgically, and thus the study design enables estimation of the treatment effect of surgery and analysis of the results of epidural injections after surgical and nonsurgical treatment. In addition, this is one of the fi rst studies to include baseline assessment of treatment preference (surgical or nonsurgical treatment) in the context of analysis of "surgical avoidance." We suspect that baseline treatment preference is associated with crossover from assigned treatment and may confound previous analyses of surgical avoidance. These results confi rm that patients who received ESI had a preference for nonsurgical treatment at baseline. Other studies that evaluate surgical avoidance associated with ESI do not include an analysis of baseline patient preference.
2 Finally, our study population is one of the largest cohorts with individual patient data, as opposed to aggregate data, and contains the longest follow-up in the literature describing the use of ESI in patients with spinal stenosis.
There are several possibilities for the poor outcome after ESI that we observed in this study. We hypothesize that the most likely explanation is that the additional volume of the ESI and/or steroid material exacerbates the underlying central stenosis and radiculopathy. It is possible that the mass effect of adding steroid and local anesthetic volume to a stenotic spinal canal may exacerbate symptoms of spinal stenosis after the immediate palliative effects of the injection have prior to enrollment were also excluded because of concerns about including patients with failed initial interventions. To inform readers of whether this population refl ects the larger population of patients who received ESI, baseline variables and change in outcome of all patients who received ESIs are reported in Tables 6, 7 , 8, 9, and 10 (Supplemental Digital Content 2, available at http://links.lww.com/BRS/A723 ). As suspected, the entire ESI cohort was similar to the subset study population, with lower patient satisfaction at baseline but similar pain scores at baseline. Similar to the 3-month subset study population, the total cohort of ESI patients had statistically signifi cantly less improvement in pain during the study period. Because the difference in outcome was also observed in the larger group of patients who received epidurals during the SPORT study period as well as the initial study cohort (3 mo), we believe that the effect observed is consistent and disproves selection bias between the groups. In conclusion, patients with spinal stenosis who received ESI had signifi cantly less improvement in outcome. There was no distinct surgical avoidance noted with ESI. Our data suggest that an intrinsic property of the ESI is likely causative because this effect was seen in both surgical and nonsurgical patients. Further prospective research is necessary to understand the indications and results of this common procedure.
suggests that there are no signifi cant differences in outcome based on the ESI technique. 34 Furthermore, we do not have information on whether the injections were fl uoroscopically guided or the nature of the corticosteroid administered (particulate vs . nonparticulate). However, the technique of these injections refl ects the actual state of clinical practice at 13 spine centers across the United States. Therefore, if signifi cant technical heterogeneity exists, then the authors would assume that this refl ects the ambiguity that exists in clinical practice. The authors would also expect that technical heterogeneity would bias the results toward no difference in outcome, not less improvement. There are other limitations that are common to subgroup analyses of prospective randomized studies. 8 Because patients were not randomized to epidural versus no-epidural treatment, there is the possibility of an unknown confounder biasing the results. Although the known common confounding variables (age, workers compensation status, duration of symptoms, obesity, smoking, etc .) were not statistically signifi cantly different between groups ( Table 1 ) , we acknowledge that an unknown confounder possibly unrelated to the ESIs (such as sagittal imbalance) may have infl uenced results and produced a type 1 error. One such possible confounder is selection bias in epidural injections. We do not have information about the factors that infl uenced patients to receive epidural injections, other than patient preference at enrollment. The only plausible factor that we identifi ed at baseline to distinguish who received an ESI was a statistically signifi cant preference for nonsurgical treatment at baseline in the ESI patients. It is possible that this baseline preference may refl ect a risk aversion behavior that may confound the outcome of surgical and nonsurgical treatment.
Another possible confounder is the limitation of the study population to patients who received epidural injections within 3 months. This decision was made prior to review of the data to exclude patients who received epidural injections as a salvage intervention after a failed attempt at nonsurgical treatment late in the study. Similarly, patients who had received ESI 
➢ Key Points
The study evaluated whether patients with spinal stenosis who received ESI had improved outcome and surgical avoidance compared with patients who did not receive ESI. ESIs were associated with signifi cantly less improvement at 4 years among all patients with spinal stenosis in SPORT. Of the surgically treated patients, ESIs were associated with longer duration of surgery and longer hospital stay. ESIs were not associated with long-term surgical avoidance.
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